Every science-fiction story needs an iconic setting. Frank Herbert’s Dune saga has no shortage of them, the most notable being the desert planet of Arrakis. Even if you’ve never read or seen Dune, ...

And, in short, that answer is… Yes. According to an article written in The Conversation, “much of Arrakis itself would indeed be habitable, albeit inhospitable.” Here’s how the scientists arrived at ...

"Arrakis is Dune, and Dune is sand," said Dune: Awakening executive producer Scott Junior, describing the desert planet that serves as the setting for the upcoming multiplayer survival game. This ...

Biotech veteran Michael Gilman “failed at retirement.” He sold his company Padlock Therapeutics to Bristol-Myers Squibb in early 2016 and contemplated calling it quits. Yet he found himself on the ...

DunePartTwo #DuneMovie #DenisVilleneuve #TimotheChalamet #PaulAtreides #Zendaya #Chani #Fremen #MuadDib #SciFiMovies ...

The three-volume, 552-page version of Frank Herbert's sci-fi classic was adapted by his son Brian and novelist Kevin J.

Arrakis Therapeutics raised $38 million in a Series A fundraising and named Michael Gilman, Ph.D., as its chairman and CEO. The financing round was led by Canaan Partners, with participation by Advent ...

Frank Herbert’s Dune is epic sci-fi storytelling with an environmental message at its heart. The novels and movies are set on the desert planet of Arrakis, which various characters dream of ...

Dune: Awakening isn’t out yet – in fact even when it does launch, it won’t be available on consoles for some time – but it is in closed beta for those lucky and keen enough to arrive on Arrakis as ...

“Dune: Part II” is one of the year’s most highly anticipated films, and it picks up where the first film left off: with Paul Atreides escaping into the desert on the planet Arrakis. It’s a ...

Lauren is an entertainment journalist and screenwriter. Her unhealthy pop culture obsession has led to bylines at Letterboxd, The Direct, Kotaku, Gizmodo and Lifehacker Australia. On the side, Lauren ...

A company developing small-molecule drugs that target RNA will receive nearly $200 million from Roche under a new partnership between the two. “We are excited to partner with Roche’s strong research ...